Dihydrocodeine bitartrate, guaifenesin, DL-methylephedrine HCl, chlorpheniramine maleate.
Each tablet contains Dihydrocodeine bitartrate 5mg, Guaifenesin 50mg, DL-Methylephedrine HCl 17.5mg and Chlorpheniramine maleate 1.5mg.
Per 100 mL syrup: Dihydrocodeine bitartrate 50 mg, DL-methylephedrine HCl 131.25 mg, guaifenesin 375 mg, chlorpheniramine maleate 15 mg.
Drug Category: Antitussives & Expectorants.
Tablet: Adults: 2 tablets orally, 3 times a day.
Children: 8 to 11 years of age: 1 tablet orally, 3 times a day.
11 to 15 years of age: 1 to 2 tablets orally, 3 times a day.
Syrup: Adult 20 mL 3 times a day.
The following patients should be advised by a physician or pharmacist prior to taking medicine: Patients who themselves, their parents or brothers are constitutionally predisposed to urticaria, contact dermatitis, allergic rhinitis, migraine, food allergy, etc.; Patients with a history of drug allergy (e.g., fever, eruption, joint pain, itching, etc.); Patients with hepatic, renal or thyroid disease, diabetes mellitus, etc.; The deblitated; Patients with high fever; Patients with cardiac disease, hypertension or the allergy; Pregnant or suspected pregnant women or nursing mothers; Patients being treated by physician.
Precautions in administration: The advised dosage & administration should be followed.
It should not be administered concomitantly with other antitussives & expectorants, cold remedy, antihistamines, sedatives, etc.
It should be administered with caution to the children.
Precautions during & after administration: When abnormalities (e.g., eruption, rash, nausea, vomiting, anorexia, dizziness, etc.) are observed, discontinue the therapy and take appropriate measures.
As drowsiness may occur, the patients should be warned not to engage in activities requiring mental alertness such as operating a motor vehicle or other machinery.
When symptoms are not improved after the repeated use, discontinue the therapy and should be advised by a physician or pharmacist.
Tablet: Protect from light and store at low humid, cool place.
Tight Container.
Use term: 3 years.
R05FA02 - opium derivatives and expectorants ; Belongs to the class of combinations of opium derivatives cough suppressants and expectorants. Used in the treatment of cough.
Codaewon syr
500 mL x 1's
Codaewon tab
10 × 10's;3 × 10's;500's